Finance

Lists
IMRX:NASDAQ
Immuneering Corp
$3.71
+1.09%
(+0.040) 1D
$3.71
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
$3.71
High
$3.75
Low
$3.54
Mkt. cap
240.27M
Avg. vol.
774.65K
Volume
849.19K
52-wk high
$8.48
52-wk low
$3.35
EPS
-$1.03
Beta
0.49
Shares outstanding
64.76M
No. of employees
65
Open
$3.71
High
$3.75
Low
$3.54
Mkt. cap
240.27M
Avg. vol.
774.65K
Volume
849.19K
52-wk high
$8.48
52-wk low
$3.35
EPS
-$1.03
Beta
0.49
Shares outstanding
64.76M
No. of employees
65
News stories
From web sources and news partners
About Immuneering Corp
CEO-
Employees65
Founded2008
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteimmuneering.com
Analyst ratings
Based on 3 analysts giving stock ratings to IMRX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current $3.71
$14.00 (+277.36%)
Average
$12.33 (+232.35%)
Lowest
$11.00 (+196.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
$14.00
+277.4%
11/12/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$11.00
+196.5%
10/29/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$12.00
+223.5%
08/17/2026
Ami Fadia
Needham
Buy
Reiterated
$18.00
+385.2%
08/05/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
$17.00
+358.2%
07/08/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$20.00
+439.1%
05/19/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$30.00
+708.6%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.25M
10.65M
14.00M
20.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.49M
4.68M
5.00M
5.06M
Operating expense
13.75M
15.34M
19.00M
25.79M
Total operating expenses
13.75M
15.34M
19.00M
25.79M
Operating income
-13.75M
-15.34M
-19.00M
-25.79M
Other non operating income
155.92K
109.01K
647.20K
390.84K
EBT including unusual items
-11.58M
-13.46M
-17.27M
-24.19M
EBT excluding unusual items
-11.74M
-13.87M
-17.27M
-24.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.58M
-13.46M
-17.27M
-24.19M
Net profit margin
-
-
-
-
Earnings per share
-0.18
-0.21
-0.27
-0.37
Interest and investment income
1.86M
1.36M
1.08M
1.20M
Interest expense
-
-
-
-
Net interest expenses
1.86M
1.36M
1.08M
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.67M
-15.25M
-18.91M
-25.69M
Gain or loss from assets sale
2.09K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps